The PAR2 signal peptide prevents premature receptor cleavage and activation

被引:4
|
作者
Liu, Belinda [1 ,2 ]
Lee, Grace [1 ]
Wu, Jiejun [1 ]
Deming, Janise [1 ]
Kuei, Chester [1 ]
Harrington, Anthony [1 ]
Wang, Lien [1 ]
Towne, Jennifer [1 ]
Lovenberg, Timothy [1 ]
Liu, Changlu [1 ]
Sun, Siquan [1 ]
机构
[1] Janssen Res & Dev LLC, San Diego, CA 92121 USA
[2] Univ Calif San Diego, Revelle Coll, San Diego, CA 92103 USA
来源
PLOS ONE | 2020年 / 15卷 / 02期
关键词
CELL-CYCLE; PROTEIN COMPARTMENTALIZATION; FUNCTIONAL-SIGNIFICANCE; ENDOPLASMIC-RETICULUM; EXPRESSION; MEMBRANE; TRANSLOCON; PROTEASES; PROTEOLYSIS; MECHANISM;
D O I
10.1371/journal.pone.0222685
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Unlike closely related GPCRs, protease-activated receptors (PAR1, PAR2, PAR3, and PAR4) have a predicted signal peptide at their N-terminus, which is encoded by a separate exon, suggesting that the signal peptides of PARs may serve an important and unique function, specific for PARs. In this report, we show that the PAR2 signal peptide, when fused to the N-terminus of IgG-Fc, effectively induced IgG-Fc secretion into culture medium, thus behaving like a classical signal peptide. The presence of PAR2 signal peptide has a strong effect on PAR2 cell surface expression, as deletion of the signal peptide (PAR2 Delta SP) led to dramatic reduction of the cell surface expression and decreased responses to trypsin or the synthetic peptide ligand (SLIGKV). However, further deletion of the tethered ligand region (SLIGKV) at the N-terminus rescued the cell surface receptor expression and the response to the synthetic peptide ligand, suggesting that the signal peptide of PAR2 may be involved in preventing PAR2 from intracellular protease activation before reaching the cell surface. Supporting this hypothesis, an Arg36Ala mutation on PAR2SP, which disabled the trypsin activation site, increased the receptor cell surface expression and the response to ligand stimulation. Similar effects were observed when PAR2 Delta SP expressing cells were treated with protease inhibitors. Our findings indicated that there is a role of the PAR2 signal peptide in preventing the premature activation of PAR2 from intracellular protease cleavage before reaching the cells surface. The same mechanism may also apply to PAR1, PAR3, and PAR4.
引用
收藏
页数:21
相关论文
共 50 条
  • [31] Protease activated receptor-2 (PAR2): possible target of phytochemicals
    Kakarala, Kavita Kumari
    Jamil, Kaiser
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2015, 33 (09): : 2003 - 2022
  • [32] Protease-activated receptor-2 (PAR2) in cardiovascular system
    Bucci, M
    Roviezzo, F
    Cirino, G
    VASCULAR PHARMACOLOGY, 2005, 43 (04) : 247 - 253
  • [33] Potent lipidated antagonists to protease-activated receptor 2 (PAR2)
    Boitano, Scott
    Hoffman, Justin
    Flynn, Andrea
    Sherwood, Cara L.
    Zhang, Zhenyu
    Patek, Renata
    Price, Theodore J.
    Vagner, Josef
    FASEB JOURNAL, 2016, 30
  • [34] Protease-activated Receptor-2 (PAR2) in Human Periodontitis
    Holzhausen, M.
    Cortelli, J. R.
    Araujo da Silva, V.
    Nobre Franco, G. C.
    Cavalca Cortelli, S.
    Vergnolle, N.
    JOURNAL OF DENTAL RESEARCH, 2010, 89 (09) : 948 - 953
  • [35] The signaling properties and functions of protease-activated receptor (PAR)1 and PAR2 in cardiomyocytes
    Sabri, A
    Andrade-Gordon, P
    Darrow, AL
    Johnson, RW
    Franke, TF
    Steinberg, SF
    CIRCULATION, 1999, 100 (18) : 6 - 6
  • [36] Selective effects of chronic hypertension on cerebral artery responses to protease-activated receptor-2 (PAR2) activation
    Sobey, CG
    Moffatt, JD
    Cocks, TM
    FASEB JOURNAL, 1999, 13 (05): : A1088 - A1088
  • [37] NMDA receptor subunit expression and PAR2 receptor activation in colospinal afferent neurons (CANs) during inflammation induced visceral hypersensitivity
    Suckow, Shelby K.
    Caudle, Robert M.
    MOLECULAR PAIN, 2009, 5
  • [38] Effects of the FXa-Receptor PAR2 (Protease Activated Receptor 2) on the progression of colorectal cancer
    Meyer, U.
    Polster, S.
    Grammbauer, S.
    Ritter, C.
    Dombrowski, F.
    Rauch, B. H.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2022, 395 (SUPPL 1) : S42 - S42
  • [39] Effect of PAR2 activation on guinea-pig mesenteric lymphatic vessels
    Chan, AK
    von der Weid, PY
    FASEB JOURNAL, 2002, 16 (04): : A77 - A77
  • [40] PAR2 Activation Protects Against Colitis but Inhibits Epithelial Wound Healing
    Trusevych, Elizabeth
    Iablokov, Vadim
    Dicay, Michael
    Beck, Paul
    MacNaughton, Wallace
    FASEB JOURNAL, 2015, 29